BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 512682)

  • 21. [Diagnostic value of the determination of creatine kinase activity and serum myoglobin concentration following graduated muscle stress].
    Weisner B; Kerrutt AM; Kunze K
    Nervenarzt; 1988 May; 59(5):278-85. PubMed ID: 3405345
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chemiluminescence of blood plasma and functional status of the erythrocytes of patients with various hereditary neuromuscular diseases].
    Sitnikov VF; Khrennikov VIu; Teselkin IuO
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):376-81. PubMed ID: 3577527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myoglobinemia in Duchenne muscular dystrophy carriers.
    Ando T; Kato T; Ohsawa M; Fukuyama Y
    Brain Dev; 1980; 2(1):87-8. PubMed ID: 7416442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blood myoglobin in children with progressive muscular dystrophy and in carriers].
    Calandi C; Baretti S; Pacciani G; Bagni P; Borsotti M; Tozzi P; Adami Lami C
    Quad Sclavo Diagn; 1984 Dec; 20(4):391-8. PubMed ID: 6537549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum muscle-specific enolase in progressive muscular dystrophy and other neuromuscular diseases.
    Mokuno K; Riku S; Matsuoka Y; Sobue I; Kato K
    J Neurol Sci; 1984 Mar; 63(3):345-52. PubMed ID: 6726277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
    Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
    Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary progressive muscular dystrophies: serum myoglobin pattern in patients with different types of muscular dystrophies.
    Pöche H; Kattner E; Beckmann R; Pernice W; Schneider V
    Clin Physiol Biochem; 1989; 7(1):40-6. PubMed ID: 2752671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunoassay of serum myoglobin in polymyositis and other conditions.
    Nishikai M; Reichlin M
    Arthritis Rheum; 1977; 20(8):1514-8. PubMed ID: 921823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnostic value of plasma myoglobin levels in the adult and fetus at-risk for Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    J Neurol Sci; 1984 Feb; 63(2):173-82. PubMed ID: 6707690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum myoglobulin levels in neuromuscular diseases].
    Verbitskiĭ AM; Shagal DI; Rozhinskaia IV; Rott GM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(11):1614-7. PubMed ID: 3434055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myoglobinaemia in Duchenne muscular dystrophy patients and carriers: A new adjunct to carrier detection.
    Adornato BT; Kagen LJ; Engel WK
    Lancet; 1978 Sep; 2(8088):499-501. PubMed ID: 79868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
    Seay AR; Ziter FA; Wu LH; Wu JT
    Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The importance of monitoring myoglobinemia in neuromuscular diseases].
    Kerndlová E; Ambler Z; Topolcan O; Dvorák I
    Cas Lek Cesk; 1987 Sep; 126(35-36):1109-11. PubMed ID: 3664583
    [No Abstract]   [Full Text] [Related]  

  • 34. Free fatty acid concentrations in normal and diseased human muscle and in blood sera from patients with neuromuscular disease.
    Susheela AK
    Clin Chim Acta; 1968 Oct; 22(2):219-22. PubMed ID: 5687088
    [No Abstract]   [Full Text] [Related]  

  • 35. Variation of serum myoglobin levels in normal individuals. With reference to the use of myoglobin measurements for the detection of women carrying genes for the X-linked muscular dystrophies.
    Nicholson LV; Walls TJ
    J Neurol Sci; 1983 Dec; 62(1-3):41-58. PubMed ID: 6686846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased serum myosin light chain 3 level in neuromuscular diseases.
    Konagaya M; Konagaya Y; Horikawa H; Takayanagi T
    Muscle Nerve; 1987 Jun; 10(5):415-21. PubMed ID: 3112571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.
    Moser H; Vogt J
    Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ineffectiveness of diltiazem in Duchenne muscular dystrophy: a placebo-controlled double-blind study].
    Toifl K; Presterl E; Graninger W
    Wien Klin Wochenschr; 1991; 103(8):232-5. PubMed ID: 1907056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum carbonic anhydrase III in neuromuscular disorders and in healthy persons after a long-distance run.
    Osterman PO; Askmark H; Wistrand PJ
    J Neurol Sci; 1985 Oct; 70(3):347-57. PubMed ID: 3932601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creatine kinase isoenzymes in neuromuscular diseases.
    Somer H; Dubowitz V; Donner M
    J Neurol Sci; 1976 Oct; 29(2-4):129-36. PubMed ID: 978205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.